Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system, a next-generation platform that ...

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...

Medtronic earned the FDA’s 510(k) clearance for its Stealth AXiS system that brings planning, navigation and robotics into ...

Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth ...